Valorising and Creating Access to Innovative Medicines in the European Union

This Perspective describes (a) the current situation, (b) challenges and initiatives, (c) and formulates recommendations to valorize and create access to innovative medicines in the EU. We are currently still far away from optimal assessment of value for money in the EU. On the one hand, valorizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Annemans, Lieven, Cleemput, Irina, Hulstaert, Frank, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190181/
https://www.ncbi.nlm.nih.gov/pubmed/22013421
http://dx.doi.org/10.3389/fphar.2011.00057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190181/
https://www.ncbi.nlm.nih.gov/pubmed/22013421
http://dx.doi.org/10.3389/fphar.2011.00057

Ejemplares similares